Bioequivalence Study of Modified-Release Gliclazide Tablets in Healthy Volunteers
Figure 3
Comparison of gliclazide plasma concentrations under fasted and fed conditions after administration of 30 mg gliclazide MR tablets of the test product, Glycon MR, (a) and the reference product, Diamicron MR, (b).
